These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2697189)

  • 1. CA-125 ovarian cancer associated antigen in cancer and pregnancy: interpretation of enzyme immunoassay and immunoradiometric assay.
    Touitou Y; Bogdan A; Darbois Y
    Anticancer Res; 1989; 9(6):1805-7. PubMed ID: 2697189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoassay of CA125 in ovarian cancer: a comparison of three assays for use in diagnosis and monitoring.
    Fisken J; Leonard RC; Roulston JE
    Dis Markers; 1989; 7(1):61-7. PubMed ID: 2653700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer markers during normal pregnancy.
    Botsis D; Sarandakou A; Kassanos D; Kontoravdis A; Rizos D; Protonotariou E; Phocas I; Creatsas G
    Anticancer Res; 1999; 19(4C):3539-41. PubMed ID: 10629649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Concentration of Ca 125 in pregnant women after spontaneous or postmenopausal gonadotrophin-induced ovulation].
    Baviera G; Purello D'Ambrosio F
    Riv Eur Sci Med Farmacol; 1989 Feb; 11(1):55-8. PubMed ID: 2798992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of tumor marker CA 125 in the cancer of the ovary: comparison of immunoenzyme and immunoradiometry methods].
    Fasquelle D; Villemain D; Meffre G; Agnius-Delord C
    Pathol Biol (Paris); 1988 Mar; 36(3):225-9. PubMed ID: 3283684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CA 19-9 enzyme immunoassay].
    Ota H; Odani H; Watanabe H; Satomura Y; Takemori Y; Okai T; Sawabu N; Mai M; Hattori N; Hashimoto T
    Gan No Rinsho; 1986 Aug; 32(9):993-7. PubMed ID: 3528560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between saliva and serum CA 125 in women with and without epithelial ovarian cancer.
    Plante M; Wong GY; Nisselbaum JS; Almadrones L; Hoskins WJ; Rubin SC
    Obstet Gynecol; 1993 Jun; 81(6):989-92. PubMed ID: 8497368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The serum concentrations of TAG-72 antigen measured with CA 72-4 IRMA in patients with ovarian carcinoma. Preliminary data.
    Gadducci A; Ferdeghini M; Ceccarini T; Prontera C; Facchini V; Bianchi R; Fioretti P
    J Nucl Med Allied Sci; 1989; 33(1):32-6. PubMed ID: 2746365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CA 15-3 is present as a novel tumor marker in the sera of patients with breast cancer and other malignancies].
    Gang Y; Adachi I; Ohkura H; Yamamoto H; Mizuguchi Y; Abe K
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2379-86. PubMed ID: 3865634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated galactosyltransferase as a new tumor marker for ovarian clear cell carcinoma.
    Nozawa S; Yajima M; Sakuma T; Udagawa Y; Kiguchi K; Sakayori M; Narisawa S; Iizuka R; Uemura M
    Cancer Res; 1990 Feb; 50(3):754-9. PubMed ID: 2105162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study of the clinical usefulness of the CA15-3 radioimmunoassay kit].
    Abe Y; Odagiri E; Jibiki K; Demura R; Demura H
    Gan No Rinsho; 1988 Oct; 34(12):1672-6. PubMed ID: 3193612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of CA 125 antigen levels in patients with ovarian cancer].
    Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
    Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of CA 72.4 in maternal serum and amniotic fluid.
    Tayyar M; Tutus A
    J Perinat Med; 1998; 26(5):400-3. PubMed ID: 10027137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum concentrations of the MCA tumor marker during pregnancy].
    Pütz I; Lang G; Winkler M; Rath W
    Zentralbl Gynakol; 1996; 118(7):409-11. PubMed ID: 8766103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study.
    Topalak O; Saygili U; Soyturk M; Karaca N; Batur Y; Uslu T; Erten O
    Gynecol Oncol; 2002 Apr; 85(1):108-13. PubMed ID: 11925128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CA125 antigen levels in obstetric and gynecologic patients.
    Niloff JM; Knapp RC; Schaetzl E; Reynolds C; Bast RC
    Obstet Gynecol; 1984 Nov; 64(5):703-7. PubMed ID: 6208522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of human ovarian tumor-associated antigens by sandwich enzyme immunoassay.
    Rao GS; Hanjani P
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):423-8. PubMed ID: 3279355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of CA 125 determination in the serum of patients with ovarian cancer].
    Bartel U; Johannsen B; Elling D
    Zentralbl Gynakol; 1989; 111(5):301-9. PubMed ID: 2728673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Place of carbohydrate antigens in the spectrum of protein tumor markers in patients with tumors at different sites].
    Reznikov IuP; Ul'ianov VI; Variukhin AS; Vanin AI; Vorontsova LP
    Vopr Onkol; 1988; 34(1):51-6. PubMed ID: 3422524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.